Parker Waichman LLP

FDA Taking Hard Look at Avastin as Breast Cancer Treatment

U.S. health regulators are questioning whether Avastin is really an effective treatment for breast cancer. A Food & Drug Administration (FDA) advisory panel is scheduled to discuss Avastin tomorrow. Avastin was the first approved therapy designed to inhibit angiogenesis, the process by which new blood vessels develop and carry vital nutrients to a tumor. Avastin […]

U.S. health regulators are questioning whether <"https://www.yourlawyer.com/practice_areas/defective_drugs">Avastin is really an effective treatment for breast cancer. A Food & Drug Administration (FDA) advisory panel is scheduled to discuss Avastin tomorrow.

Avastin was the first approved therapy designed to inhibit angiogenesis, the process by which new blood vessels develop and carry vital nutrients to a tumor. Avastin was approved by the Food & Drug Administration (FDA) in 2004 to treat metastatic colon cancer, and in 2006, the agency approved it as a treatment for non-small cell lung cancer. In 2008, the FDA also approved Avastin as a metastatic breast cancer treatment in combination with a chemotherapy drug called paclitaxel, and in May 2009, it was approved to treat glioblastoma multiforme, an incurable brain cancer.

According to The Wall Street Journal, Avastin’s breast cancer indication was granted under an accelerated process that is based on initial positive studies. Companies then have to submit additional data to gain full approval. The Avastin approval was granted even though an FDA advisory panel had earlier voted 5-4 against it, the Journal said.

The FDA approval of Avastin for breast cancer was based on a study that didn’t show a statistically significant increase in overall survival. According to the Journal, the study found that patients treated with Avastin and paclitaxel added five-and-a-half months to median progression-free survive.

Roche, at the FDA’s request, then conducted two additional studies and submitted them to the FDA for full approval of Avastin. According to materials posted on the FDA’s Web site in advance of tomorrow’s meeting, those studies “failed to confirm the magnitude” of the benefit seen in the first study that supported Avastin’s approval. In one, the Journal said women treated with Avastin lived less than a month longer without their disease progressing compared with those who did not receive the drug. The other study showed a difference of no more than 2.9 month.

The materials posted on the FDA Web site also raise concerns about Avastin’s side effects, including bleeding, the Journal said.

According to The Wall Street Journal report, the FDA could ultimately decide to rescind the breast-cancer approval for Avastin, although it has not said specifically that it is considering that option.

Avastin has long been a subject of safety concerns. It has been linked to a higher risk of blood clots in the veins. And in December 2008, its maker reported that some Avastin patients had experienced eye inflammation when it was used off-label to treat an eye condition.

This past fall, an Avastin trial was halted after six patients developed clinical congestive heart failure. The late-stage trial, known as E5103, was testing Avastin in combination with chemotherapy for treatment of early-stage breast cancer. The trial was one of eight studying Avastin as a treatment for preventing relapse after surgery, known as adjuvant therapy.

Five of the six cases of congestive heart failure were “resolved” after the patients stopped taking both Avastin and the chemotherapy treatment. No information was available at the time the trial was halted for the sixth patient, but none of those who developed the disorder had died.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Thank you Parker Waichman. Working with Christina Morace through this long process made it easy and rewarding. Always pleasant to speak with and answered any of my questions and concerns. She kept me informed on all the documents needed on a timely basis and all the updates on my case. I sincerely recommend this Law Firm for the professional and knowledgeable workers. Thank you Carrie Hargrove Erskine
Carrie Hargrove
4 months ago
5 Star Reviews 150
A very professional Law Firm more e-mail updates would be great!
randal lee
6 years ago
5 Star Reviews 150
Everyone I have been in contact with has been very professional, helpful and friendly. I'm sure it will be the same moving forward. Thank you.
Linda Mierisch
6 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038